Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 178 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia

 		Chronic Myelogenous Leukemia - Chronic Phase Phase2 United States

Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria

 		Uncomplicated Plasmodium Falciparum Malaria Phase2 Kenya
Côte D'Ivoire
Uganda
Ghana
View All

A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

 		Primary Prevention of Atherosclerotic Cardiovascular Disease Phase3 United States
Belgium
Australia
Brazil
Colombia
Canada
China
Bulgaria
Czechia
Austria
Argentina
Croatia
View All

Study of Efficacy and Safety of LCZ696/Amlodipine in Grade 1 and 2 Hypertension Patients Uncontrolled by LCZ696 Monotherapy

 		Hypertension Phase3 Japan

Characterizing Guideline Adoption and Treatment Quality in Clinical Routine of German HFrEF Care

 		Heart Failure Germany

A Proof of Concept and Dose-finding Study of XXB750 in Patients With Heart Failure

 		Heart Failure Phase2 United States
Spain
Italy
Slovakia
China
Germany
Bulgaria
Netherlands
Japan
Denmark
Taiwan
Portugal
France
View All

Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis

 		Multiple Sclerosis Phase4 Taiwan

Efficacy and Safety of Secukinumab in Patients With New Onset of Giant Cell Arteritis Who Are in Clinical Remission

 		Giant Cell Arteritis Phase3 Germany

Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis

 		Lupus Nephritis Phase3 United States
Germany
France
India
Thailand
Spain
Colombia
China
Brazil
United Kingdom
Romania
Hungary
Korea, Republic of
Argentina
Italy
Guatemala
Vietnam
Taiwan
Lithuania
Malaysia
Hong Kong
Mexico
Canada
Czechia
Chile
Singapore
Estonia
View All

A Multi-center Study to Evaluate the Safety, Tolerability and Efficacy of TIN816 in Patients at Risk for Acute Kidney Injury Following Cardiac Surgery.

 		Acute Kidney Injury Following Cardiac Surgery Phase2 Germany
Spain
Hungary
Argentina
Brazil
Belgium
France
Czechia
Singapore
Taiwan
Estonia
View All